Magtidelira 33Mg

U.P.A Magtidelira 33 (Semaglutide 3mg/ Tirzepatide30mg) - Hybrid GLP-1 Weight Loss Pen

The U.P.A Magtidelira 33 Pre-Filled Pen offers a revolutionary combination of 3mg semaglutide and 30mg tirzepatide in a

convenient pre-filled format, ideal for individuals seeking advanced weight loss support, enhanced appetite control, and

improved metabolic health. This innovative hybrid pen leverages the complementary mechanisms of two powerful GLP-1

receptor agonists to deliver superior results compared to single-agent therapies.

What ls Magtidelira 33?

Magtidelira 33 is a cutting-edge hybrid medication that combines:

• Semaglutide (3mg) - A GLP-1 receptor agonist originally developed for Type 2 Diabetes

•Tirzepatide (30mg) - A dual GIP and GLP-1 receptor agonist with enhanced metabolic effects

This combination offers synergistic benefits:

•Enhanced appetite suppression

• Accelerated fat loss

• Improved glucose regulation

• Greater metabolic improvements

• More significant weight reduction than single agents

This innovative hybrid approach provides a cost-effective alternative at R1980 compared to purchasing separate pens

(R4000+).

9 How Does the U.P.A Magtidelira 33 Pen Work?

The U.P.A Magtidelira 33 pen works through multiple complementary pathways to promote safe, consistent weight loss:

• Controls hunger signals through two distinct mechanisms

• Enhances satiety after meals for easier calorie deficits

• Delays gastric emptying more effectively than single agents

• Supports insulin sensitivity for stable glucose levels

• Provides 24/7 appetite control through dual-agonist action

This makes it ideal for those struggling with stubborn weight gain, insulin resistance, or poor appetite regulation. Clinical

evidence suggests combination therapy may produce up to 25% body weight reduction with consistent use.

V Key Benefits of U.P.A Magtidelira 33 Pen

Superior Fat Loss - Enhanced appetite suppression and metabolic effects

Non-Stimulant Formula - Zero jittery side effects, unlike caffeine-based burners

a Enhanced Metabolic Support - Improved blood sugar and glucagon control

Pre-Filled Convenience - Ready-to-use pen for easy administration

Multifaceted Support - Effective for fitness cutting cycles, metabolic therapy, or clinical weight control

Cost Efficiency -One hybrid pen instead of purchasing separate medications

How to Use the U.P.A Magtidelira 33 Pen

•**Administration**:

• Remove the cap and attach a new needle

• Dial the prescribed dose

• Inject subcutaneously into the abdomen or outer thigh